Protein electrophoresis and immunoglobulin analysis in HIV-infected patients

American Journal of Clinical Pathology

Volumn 128, Issue 4, 2007, Pages 596-603

  Konstantinopoulos, Panagiotis A ^a   Dezube, Bruce J ^a,c   Pantanowitz, Liron ^b   Horowitz, Gary L ^a   Beckwith, Bruce A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

HIV; Immunoglobulins; Monoclonal banding; Protein electrophoresis

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; OLIGOCLONAL BAND;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; HYPOGAMMAGLOBULINEMIA; IMMUNE STATUS; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ELECTROPHORESIS; SCHOOL CHILD; SEX DIFFERENCE; VIRUS LOAD;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; AGED; CHILD; CROSS-SECTIONAL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HIV INFECTIONS; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULINS; MALE; MASSACHUSETTS; MIDDLE AGED;

EID: 35348865545     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/QWTQFGA9FXN02YME     Document Type: Article

References (37)

1. Heriot K, Hallquist AE, Tomar RH. Paraproteinemia in patients with acquired immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome (LAS). Clin Chem. 1985;31:1224-1226.
2. Le Carrer D. Serum Protein Electrophoresis and Immunofixation: Illustrated Interpretations. Washington, DC: American Association for Clinical Chemistry; 1994:94-108.
3. Kumar S, Kumar D, Schnadig VJ, et al. Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol. 1994;102:633-639.
4. Nosari AM, Landonio G, Cantoni S, et al. Multiple myeloma associated to HIV infection: report of two patients. Eur J Haematol. 1996;56:98-99.
5. Lallemand F, Fritsch L, Cywiner-Golenzer C, et al. Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression. J Am Acad Dermatol. 1998;39:506-508.
6. Pantanowitz L, Dezube BJ. Multiple myeloma and HIV infection: casual or causal coincidence [editorial]? AIDS Read. 2003;13:386-387.
7. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
8. Cauda R, Lucia MB, Marasca G, et al. Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy [letter]. Eur J Haematol. 1999;63:134-135.
9. Amara S, Dezube BJ, Cooley TP, et al. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients. Clin Infect Dis. 2006;43:1198-1205.
10. Papadopoulos NM, Elin RJ, Wilson DM. Incidence of γ-globulin banding in a healthy population by high-resolution electrophoresis. Clin Chem. 1982;28(4 pt 1):707-708.
11. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564-569.
12. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance: a review. Immunol Rev. 2003;194:112-139.
13. Papadopoulos NM, Lane HC, Costello R, et al. Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1985;35:43-46.
14. Sala PG, Mazzolini S, Tonutti E, et al. Monoclonal immunoglobulins in HTLV III-positive sera [letter]. Clin Chem. 1986;32:574.
15. Crapper RM, Deam DR, Mackay IR. Paraproteinemias in homosexual men with HIV infection: lack of association with abnormal clinical or immunologic findings. Am J Clin Pathol. 1987;88:348-351.
16. Sala PG, Mazzolini S, Tonutti E, et al. Monoclonal-oligoclonal immunoglobulins in HTLV III infected subjects: HTLV III-induced or HTLV III-associated? Boll Ist Sieroter Milan. 1987;66:14-17.
17. Lefrere JJ, Fine JM, Lambin P, et al. Monoclonal gammopathies in asymptomatic HIV-seropositive patients [letter]. Clin Chem. 1987;33:1697-1698.
18. Papadopoulos NM, Costello R. Oligoclonal immunoglobulins in the sera of healthy subjects at risk for AIDS. Clin Biochem. 1987;20:257-258.
19. Taichman DB, Bayer K, Senior M, et al. Oligoclonal immunoglobulins in HIV-antibody-positive serum. Clin Chem. 1988;34:2377.
20. Bratt G, Waldenlind L, Von Krogh G, et al. A prospective study of immunoglobulin changes in relation to human immunodeficiency virus infection in a cohort of homosexual men. Scand J Immunol. 1989;29:589-595.
21. Amadori A, Gallo P, Zamarchi R, et al. IgG oligoclonal bands in sera of HIV-1 infected patients are mainly directed against HIV-1 determinants. AIDS Res Hum Retroviruses. 1990;6:581-586.
22. Frankel EB, Greenberg ML, Makuku S, et al. Oligoclonal banding in AIDS and hemophilia. Mt Sinai J Med. 1993;60:232-237.
23. Leffere JJ, Debbia M, Lambin P. Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol. 1993;84:151-155.
24. Pontet F, Gue X, Mazeron MC, et al. Qualitative immunoglobulin abnormalities in HIV-positive patients: long-term follow-up. Clin Chem Lab Med. 1998;36:493-496.
25. Tormey WP. Low concentration monoclonal and oligoclonal bands in serum and urine using the Sebia Hydragel Protein Electrophoresis System [letter]. Clin Chem Lab Med. 1998;36:253-254.
26. Chess Q, Daniels J, North E, et al. Serum immunoglobulin elevations in the acquired immunodeficiency syndrome (AIDS): IgG, IgA, IgM and IgD. Diagn Immunol. 1984;2:148-153.
27. Papadopoulos NM, Costello R, Ceroni M, et al. Identification of HIV-specific oligoclonal immunoglobulins in serum of carriers of HIV antibody. Clin Chem. 1988;34:973-975.
28. Ng VL, Hwang KM, Reyes GR, et al. High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complex. Blood. 1988;71:1397-1401.
29. Ng VL, Chen KH, Hwang K, et al. The clinical significance of human immunodeficiency virus type 1-associated paraproteins. Blood. 1989;74:2471-2475.
30. Konrad RJ, Kricka LJ, Goodman DB, et al. Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med. 1993;328:1817-1819.
31. Goeder T, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignancy disorders. Lancet. 1998;351:1833-1839.
32. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol. 2000;27:390-401.
33. Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004;101:317-324.
34. Dezube BJ, Aboulafia DM, Pantanowitz L. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma. AIDS Read. 2004;14:372-374, 377-379.
35. Redgrave BE, Stone SF, French MA, et al. The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med. 2005;6:307-312.
36. Cutolo M. Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum Dis Clin North Am. 2000;26:881-895.
37. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci. 1998;840:45-50.